Systemic Enzyme Therapy during expectant management of preeclampsia: controlled randomised trial

Cover Page


Cite item

Full Text

Abstract

Systemic Enzyme Therapy (medicine Wobenzym) or standard therapy randomly allocated of pregnant women with mild preeclampsia. Outcome for mothers and fetus, mechanism of action discussed.

About the authors

Margarita Aleksandrovna Repina

North-Western State Medical University named after I. I. Mechnikov

Email: Margarita.Safronova@szgmu.ru
professor

Tat’yana Markovna Korzo

Maternity hospital N 6

Email: Margarita.Safronova@szgmu.ru
physician

References

  1. Репина М. А., Корзо Т. М., Папаян Л. П., Красовская Г. А, Сумская Г. Ф. Современные подходы к коррекции нарушений гемостаза при беременности, осложненной гестозом. СПб.; 1998
  2. Шитикова А. С., Каргин В. Д., Белязо О. Е. и др. Морфологическая оценка повышенной внутрисосудистой активации тромбоцитов. Методич. реком. СПб.; 1996
  3. Askie L. M., Duley L., Henderson-Smart D. et al. Antiplatelet agents for prevention of preeclampsia: meta-analysis of individual patient data. Lancet. 2007; 369: 1791-8
  4. Dekker G. A., Sibai B. M. Low - dose aspirin in the prevention of preeclampsia and fetal growth retardation. Am. J. Obstet. Gynecol. 1993; 168: 214-7
  5. Duley L., Henderson-Smart D., Knight M., King J. F. Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst. Rev. 2004: CD 004659
  6. Lockwood C. J., Krikun G., Rahman M. et al. The role of decidualization in regulating endometrial hemostasis during menstrual cycle, gestation and in pathological states. Semin. Thromb. Hemost. 2007; 33: 111-7
  7. Patrono C. Aspirin as an antiplatelet drug. N. Eng. J. Med.1994; 330: 1287-94
  8. Schiff E., Barkai G., Ben-Baruch G., Mashiach S. Low - dose aspirin does not influence the clinical course of women with mild pregnancy induced hypertension. Obstet. Gynecol.1990; 76: 742-4

Copyright (c) 2015 Repina M.A., Korzo T.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies